Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. - Wikidata - wikimedia - TriplyDB

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

http://www.wikidata.org/entity/Q35691658

about

Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies"Effector mechanisms of rejection Antibody-mediated rejection: emergence of animal models to answer clinical questions Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy Non-MHC antigenic targets of the humoral immune response in transplantation Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury.Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome.Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis HLA and MICA: targets of antibody-mediated rejection in heart transplantation.Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1.Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile?Role of anti-vimentin antibodies in allograft rejection.Report from a consensus conference on antibody-mediated rejection in heart transplantation Vimentin is a target of PKCβ phosphorylation in MCP-1-activated primary human monocytes.Report from a consensus conference on the sensitized patient awaiting heart transplantation Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.DNA vaccines for transplantation.Overview of pathophysiology and treatment of human lupus nephritis.The importance of non-HLA antibodies in transplantation.The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.Role of alloimmunity and autoimmunity in allograft rejection.Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.Antibodies beyond HLA.Autoimmune Reactivity in Graft Injury: Player or Bystander?Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.Exosomes Expressing the Self-Antigens Myosin and Vimentin Play an Important Role in Syngeneic Cardiac Transplant Rejection Induced by Antibodies to Cardiac Myosin.Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection.Vimentin and Anti Vimentin Antibodies in Chagas' Disease.

P2860

Q26780481-A1BEEE76-1958-4AEA-8A05-620CA68475F8 Q27027082-6FB75924-915E-413D-B4EF-D1574D29BC4E Q27692014-37006646-CABA-4489-8DC4-F32725026340 Q28084366-55174927-F1B8-4180-9A67-5D52E05E1410 Q34056345-5072C21F-AD27-4152-8485-75118154623A Q34238488-9F89AEAC-0C47-4E08-B3A1-D79007789373 Q34259047-D96D00C3-A288-4C49-A0A1-BA97735AF6A0 Q34433298-7B27A256-FDDD-46D7-A566-47BC4E16375B Q34595998-04FEFB23-776E-4922-9B5E-E30AC9E488C2 Q34684028-525FDED7-DD4E-442D-B148-550EBA6C6CFB Q35324023-175EB7D6-F5AC-4447-A6E6-DA4FBF1B26F3 Q35954030-DEAE8053-556B-478F-BD5A-FF1243313F6D Q36085051-C6FFF555-A1A2-49B3-BFD1-310A74F5D6CD Q36299959-7B56A8EA-D5E1-450D-AA51-95411B2C680D Q36584523-B8218229-8846-4BA1-BBA8-DFD63A4BE429 Q36979114-83F23FA8-11D9-48FE-B847-0F5D79F0D6B3 Q37032289-75033617-3445-403B-BB44-2566D9D4E38C Q37163146-C6445343-3090-4BB9-8EFA-BE5714CB8C93 Q37286553-5A9183C0-4DFA-40F1-8F0B-6C895AE972C1 Q37313051-052D31EA-C44C-47AC-B81B-7940614C8E31 Q37319302-AAE5CC5A-FDE8-421B-9C3D-ECB64CB2E9C7 Q37414657-AC3D5576-6E3E-41AE-88F4-C3853AE49E70 Q37660263-70D60B18-995D-4348-B3E1-935FF4849689 Q37725897-781200CB-A11E-4AA2-89DF-2F64358D73E2 Q38876110-60693E1F-39F2-429C-82C6-234A39362722 Q38877375-7598061E-1E13-4013-AE45-4AD12FE5D821 Q38995184-FFCEE26A-958A-43D9-985D-E07BC6CEFFFC Q39228029-C5E7D7D4-3111-4C24-B252-623041848EEA Q41226453-0BA6FB0D-359B-4CA9-9E85-4583E54B2DA4 Q41849097-1A18ADAD-05DA-4B86-BB36-0C023E55E748 Q43865301-6B1D4301-5CFA-4A2C-97D9-D2180CCF2047 Q45763669-73EE6717-C7C0-4BB5-AEA2-398078ECD828 Q46920946-CD497FA9-4C62-45ED-A975-D8B85404216C Q48055653-C58349CF-140F-4266-9095-8685BA3817BC Q50117728-A7C114A9-B033-4680-BCDC-A685D03BAE38 Q51249816-0980918D-162A-47B5-A468-7626EEFD68A5 Q53241382-5C7DE96A-DFDE-47D5-BB45-F5A923479489 Q54256062-6F0AA671-ECE4-4B40-AEE6-2CB76FFC99C3

P2860

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

http://www.wikidata.org/entity/Q35691658

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

@ast

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

@en

type

label

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

@ast

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

@en

prefLabel

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

@ast

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

@en

P1433

Q35691658-2B693A90-1F71-4E70-8319-2C55E0857856

P1476

Q35691658-A6FFD37D-3803-4EE5-84DD-441654552297

P2093

Q35691658-504AF25F-53BF-40DF-84B5-9BF0741AF3EB

Q35691658-7602A14B-7C5B-42F3-A1BF-0F45643E52EC

Q35691658-C2CC619C-B84C-425F-9B41-DE0131CCE52E

Q35691658-D8808FE7-F902-4BFB-9B5F-542EBCB5AD70

Q35691658-E7D36DC5-96BA-4DF6-8F17-9B4700D18276

P2860

Q35691658-04B58FE0-3876-4FB0-B03D-15204E24FE0A

Q35691658-0A7A0E58-940A-466A-AF9D-85693E0E75A2

Q35691658-0D7EA61E-737D-400B-A835-A8998211829F

Q35691658-0D814BB5-D3AA-4D14-9B45-15C2CD7D866D

Q35691658-1E0AC379-CF9D-4449-80CA-238B71ADA5EA

Q35691658-20B28D87-3141-41A0-A529-33E4F5A135EE

Q35691658-297D6AB5-0F6C-44D6-8AF9-F84BDBA3FB3A

Q35691658-31F1E1A6-E41E-4A2E-9646-7E0E8CEEADB8

Q35691658-321AA272-8755-4406-918B-F63CF121B71B

Q35691658-388C685D-2BCA-4FEA-A5C2-F8A365875861

P304

Q35691658-5BD66014-3ABD-4828-B8B9-CACEB0718925

P31

Q35691658-ED70D576-5566-42D1-B33A-33C68668648C

P356

Q35691658-66DCB89A-11B7-4AFB-B4F4-91E33BA94EB9

P407

Q35691658-F2595940-853B-43A9-AACE-D098785C28E1

P433

Q35691658-4C1D3A15-8AAD-420F-9B96-4B2EB90FABD6

P478

Q35691658-3E8CB287-1C2E-4642-BA0E-55EC8D8F7FC6

P50

Q35691658-6ABAF93F-E3ED-437B-B825-77770C496990

P577

Q35691658-B2E01E7D-C5A0-4292-BE12-88F7D38EF009

P5875

Q35691658-66F884C8-C7A0-4CC3-9403-23044DC02606

P698

Q35691658-0FEAE9FA-426E-4BFF-B056-740FF7D3430E

P921

Q35691658-28A23B59-6FA4-45A1-9A8E-EDFB228CE209

P932

Q35691658-1F8A8C82-2072-4A0D-BB18-9A4B04D3CFE3

P356

AJPATH.2007.060728

P1433

The American Journal of Pathology

P1476

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts

@en

P2093

Angela Holder

http://www.w3.org/2001/XMLSchema#string

Ann McCormack

http://www.w3.org/2001/XMLSchema#string

Balakrishnan Mahesh

http://www.w3.org/2001/XMLSchema#string

Marlene L Rose

http://www.w3.org/2001/XMLSchema#string

Padmini Sarathchandra

http://www.w3.org/2001/XMLSchema#string

P2860

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease.

Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2.

Regulatory T cells in autoimmmunity*.

Complement as a mediator of vascular inflammation and activation in allografts.

Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.

Vimentin is secreted by activated macrophages.

Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection.

Peripheral T cell tolerance.

Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.

P304

1415-1427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2007.060728

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51376629

http://www.w3.org/2001/XMLSchema#string

P698

17392180

http://www.w3.org/2001/XMLSchema#string

P921

P932

1829474

http://www.w3.org/2001/XMLSchema#string